Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,20097,818,1.23 [1.11-1.38],0.0001433116973476
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19460,239,1.66 [1.36-2.02],7.125656720833319e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15029,813,1.58 [1.41-1.77],5.507042916374846e-15
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,20774,553,1.51 [1.33-1.73],8.685564028569941e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,21940,252,1.64 [1.35-1.99],5.102402511863846e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,21940,252,1.64 [1.35-1.99],5.102402511863846e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19721,503,1.47 [1.28-1.69],6.947549533105118e-08
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18400,1424,1.29 [1.18-1.41],1.0139161212236312e-08
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20746,149,2.48 [1.92-3.19],1.95083541003435e-12
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22164,159,1.69 [1.33-2.16],1.8788253554473567e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20732,135,2.43 [1.86-3.17],6.031739073205502e-11
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21283,686,1.77 [1.56-2.01],3.745810695052616e-19
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21257,660,1.78 [1.56-2.02],9.914641215801305e-19
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,18250,1274,1.23 [1.12-1.35],1.4396606298828704e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,18152,1176,1.21 [1.10-1.34],7.580369922212907e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17026,50,2.11 [1.37-3.23],0.0006363615542121
PLA2G10,Group 10 secretory phospholipase A2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17073,97,2.47 [1.82-3.35],7.250830951680144e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter V Mental and behavioural disorders,Any mental disorder,19938,682,1.27 [1.12-1.43],0.0001363489987011
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Neurological diseases,19897,1295,1.18 [1.08-1.28],0.0003454663533312
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22174,533,1.27 [1.11-1.45],0.000536602682385
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Epilepsy,21803,162,1.57 [1.24-1.99],0.0001891107894242
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23164,89,1.86 [1.35-2.55],0.0001252198133946
PLA2G10,Group 10 secretory phospholipase A2,Chapter VI Diseases of the nervous system,Hemiplegia,23133,58,2.34 [1.59-3.44],1.5905208980252314e-05
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20540,140,1.59 [1.23-2.06],0.0004341233505191
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22539,248,1.57 [1.29-1.91],6.718824649472565e-06
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23101,70,2.85 [1.97-4.13],2.7548257258001338e-08
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2573,70,2.65 [1.82-3.86],4.176188551920416e-07
PLA2G10,Group 10 secretory phospholipase A2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20598,70,3.03 [2.08-4.43],9.952078686353013e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,15867,3714,1.30 [1.22-1.39],4.628104722508085e-15
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16745,2431,1.30 [1.21-1.41],2.9687741019559784e-12
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertension,16787,2473,1.32 [1.23-1.42],1.5076919525925905e-13
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14419,105,2.73 [2.01-3.72],1.654899470758323e-10
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",20822,1655,1.33 [1.23-1.44],8.623611378649942e-12
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Angina pectoris,20087,920,1.32 [1.19-1.47],3.0903882087655064e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22079,334,1.33 [1.13-1.58],0.0008781015366031
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22478,733,1.37 [1.22-1.54],1.1955799551315617e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19666,499,1.50 [1.31-1.73],1.2656497356168433e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20555,1412,1.36 [1.24-1.48],9.567636076964932e-12
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,12097,596,1.50 [1.31-1.72],8.719283063607141e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22218,312,1.49 [1.25-1.78],8.750746730817674e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22483,182,1.60 [1.28-2.00],4.19744395506278e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22508,164,1.67 [1.32-2.11],2.197872158507354e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22593,146,1.64 [1.28-2.11],0.000109434402671
PLA2G10,Group 10 secretory phospholipase A2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22193,141,1.60 [1.24-2.06],0.0003177010413414
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18294,1980,1.29 [1.19-1.38],2.7304722262719145e-11
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,21391,249,1.52 [1.25-1.85],2.2768031019734097e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",21354,212,1.61 [1.31-1.99],8.393425412270356e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22532,270,1.61 [1.33-1.93],5.436113321983713e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22529,267,1.63 [1.36-1.97],2.456125535329009e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,20991,839,1.35 [1.21-1.50],7.08256279496818e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Early onset COPD,22194,194,1.78 [1.42-2.22],4.169508791143934e-07
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22227,227,1.67 [1.35-2.05],1.400756580286486e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22227,227,1.67 [1.35-2.05],1.400756580286486e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22106,650,1.24 [1.09-1.39],0.000628773781117
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Asthma,15955,650,1.31 [1.15-1.48],2.3576314552930475e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15610,650,1.31 [1.16-1.48],1.928735190084585e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",15945,640,1.29 [1.14-1.46],6.056924173661088e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23084,94,2.00 [1.46-2.73],1.2748661969999075e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22353,74,2.34 [1.65-3.32],1.6199123891100038e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23166,74,2.33 [1.64-3.30],2.052031280100668e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22347,68,2.30 [1.60-3.31],6.666922562667958e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17999,319,1.40 [1.18-1.67],0.0001454817213694
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other diseases of intestines,18119,1786,1.14 [1.06-1.24],0.0005719844548902
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16510,177,1.65 [1.31-2.07],1.924114645732394e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Constipation,21949,161,1.59 [1.25-2.02],0.0001350091789477
PLA2G10,Group 10 secretory phospholipase A2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22131,314,1.37 [1.15-1.63],0.0003966825284728
PLA2G10,Group 10 secretory phospholipase A2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22339,296,1.37 [1.15-1.64],0.0005099482104265
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,17996,2337,1.22 [1.14-1.31],2.101446703893932e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20722,302,1.66 [1.39-1.98],2.5702604967205076e-08
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,20756,72,2.36 [1.65-3.36],2.532065447757664e-06
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,20775,91,2.67 [1.95-3.67],1.330528308019299e-09
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,20774,90,2.03 [1.47-2.80],1.7476341695444712e-05
PLA2G10,Group 10 secretory phospholipase A2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,22968,73,2.00 [1.40-2.85],0.0001264427573688
